Identification of significantly mutated subnetworks in the breast cancer genome

Abstract Recent studies showed that somatic cancer mutations target genes that are in specific signaling and cellular pathways. However, in each patient only a few of the pathway genes are mutated. Current approaches consider only existing pathways and ignore the topology of the pathways. For this r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rasif Ajwad, Michael Domaratzki, Qian Liu, Nikta Feizi, Pingzhao Hu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/35eb7bde4a5b4476838f5f4ffa421d0f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35eb7bde4a5b4476838f5f4ffa421d0f
record_format dspace
spelling oai:doaj.org-article:35eb7bde4a5b4476838f5f4ffa421d0f2021-12-02T14:01:32ZIdentification of significantly mutated subnetworks in the breast cancer genome10.1038/s41598-020-80204-52045-2322https://doaj.org/article/35eb7bde4a5b4476838f5f4ffa421d0f2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80204-5https://doaj.org/toc/2045-2322Abstract Recent studies showed that somatic cancer mutations target genes that are in specific signaling and cellular pathways. However, in each patient only a few of the pathway genes are mutated. Current approaches consider only existing pathways and ignore the topology of the pathways. For this reason, new efforts have been focused on identifying significantly mutated subnetworks and associating them with cancer characteristics. We applied two well-established network analysis approaches to identify significantly mutated subnetworks in the breast cancer genome. We took network topology into account for measuring the mutation similarity of a gene-pair to allow us to infer the significantly mutated subnetworks. Our goals are to evaluate whether the identified subnetworks can be used as biomarkers for predicting breast cancer patient survival and provide the potential mechanisms of the pathways enriched in the subnetworks, with the aim of improving breast cancer treatment. Using the copy number alteration (CNA) datasets from the METABRIC (Molecular Taxonomy of Breast Cancer International Consortium) study, we identified a significantly mutated yet clinically and functionally relevant subnetwork using two graph-based clustering algorithms. The mutational pattern of the subnetwork is significantly associated with breast cancer survival. The genes in the subnetwork are significantly enriched in retinol metabolism KEGG pathway. Our results show that breast cancer treatment with retinoids may be a potential personalized therapy for breast cancer patients since the CNA patterns of the breast cancer patients can imply whether the retinoids pathway is altered. We also showed that applying multiple bioinformatics algorithms at the same time has the potential to identify new network-based biomarkers, which may be useful for stratifying cancer patients for choosing optimal treatments.Rasif AjwadMichael DomaratzkiQian LiuNikta FeiziPingzhao HuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rasif Ajwad
Michael Domaratzki
Qian Liu
Nikta Feizi
Pingzhao Hu
Identification of significantly mutated subnetworks in the breast cancer genome
description Abstract Recent studies showed that somatic cancer mutations target genes that are in specific signaling and cellular pathways. However, in each patient only a few of the pathway genes are mutated. Current approaches consider only existing pathways and ignore the topology of the pathways. For this reason, new efforts have been focused on identifying significantly mutated subnetworks and associating them with cancer characteristics. We applied two well-established network analysis approaches to identify significantly mutated subnetworks in the breast cancer genome. We took network topology into account for measuring the mutation similarity of a gene-pair to allow us to infer the significantly mutated subnetworks. Our goals are to evaluate whether the identified subnetworks can be used as biomarkers for predicting breast cancer patient survival and provide the potential mechanisms of the pathways enriched in the subnetworks, with the aim of improving breast cancer treatment. Using the copy number alteration (CNA) datasets from the METABRIC (Molecular Taxonomy of Breast Cancer International Consortium) study, we identified a significantly mutated yet clinically and functionally relevant subnetwork using two graph-based clustering algorithms. The mutational pattern of the subnetwork is significantly associated with breast cancer survival. The genes in the subnetwork are significantly enriched in retinol metabolism KEGG pathway. Our results show that breast cancer treatment with retinoids may be a potential personalized therapy for breast cancer patients since the CNA patterns of the breast cancer patients can imply whether the retinoids pathway is altered. We also showed that applying multiple bioinformatics algorithms at the same time has the potential to identify new network-based biomarkers, which may be useful for stratifying cancer patients for choosing optimal treatments.
format article
author Rasif Ajwad
Michael Domaratzki
Qian Liu
Nikta Feizi
Pingzhao Hu
author_facet Rasif Ajwad
Michael Domaratzki
Qian Liu
Nikta Feizi
Pingzhao Hu
author_sort Rasif Ajwad
title Identification of significantly mutated subnetworks in the breast cancer genome
title_short Identification of significantly mutated subnetworks in the breast cancer genome
title_full Identification of significantly mutated subnetworks in the breast cancer genome
title_fullStr Identification of significantly mutated subnetworks in the breast cancer genome
title_full_unstemmed Identification of significantly mutated subnetworks in the breast cancer genome
title_sort identification of significantly mutated subnetworks in the breast cancer genome
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/35eb7bde4a5b4476838f5f4ffa421d0f
work_keys_str_mv AT rasifajwad identificationofsignificantlymutatedsubnetworksinthebreastcancergenome
AT michaeldomaratzki identificationofsignificantlymutatedsubnetworksinthebreastcancergenome
AT qianliu identificationofsignificantlymutatedsubnetworksinthebreastcancergenome
AT niktafeizi identificationofsignificantlymutatedsubnetworksinthebreastcancergenome
AT pingzhaohu identificationofsignificantlymutatedsubnetworksinthebreastcancergenome
_version_ 1718392132488658944